Alterity Therapeutics Limited (ATHE) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Alterity Therapeutics Lim...

    NASDAQ: ATHE · Real-Time Price · USD
    4.21
    0.02 (0.48%)
    At close: Oct 03, 2025, 3:59 PM
    4.24
    0.83%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Alterity Therapeutics Income Statement

    Financials in AUD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2025 Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021 Dec 31, 2020
    Revenue
    		 3.83M 1.61M 2.12M 1.9M 1.53M 2.39M 2.76M 2.36M 2.46M 1.88M
    Cost of Revenue
    		 63.92K 63.6K 73.61K 73.92K 52.27K 50K 22.68K 31.54K 39.74K 35.63K
    Gross Profit
    		 3.77M 1.54M 2.04M 1.83M 1.48M 2.34M 2.74M 2.33M 2.42M 1.85M
    Operating Income
    		 -7.09M -7.49M -12.98M -4.5M -7.77M -10.75M -10.46M -10.16M -9.88M -9.64M
    Interest Income
    		 n/a n/a 150.02K 118.4K 5.06K 11.38K 1.15K 1.35K 14.12K 6.55K
    Pretax Income
    		 -4.91M -8.78M -12.57M -4.39M -7.3M -10.31M -8.73M -8.72M -8.99M -10.45M
    Net Income
    		 -4.97M -7.17M -12.62M -6.51M -5.77M -8.03M -6.26M -6.58M -6.75M -8.56M
    Selling & General & Admin
    		 2.17M 3.31M 2.68M 2.08M 2.29M 2.94M 2.46M 3.37M 3.36M 3.8M
    Research & Development
    		 8.69M 5.72M 12.28M 6.36M 5.43M 7.76M 7.98M 6.76M 6.48M 5.81M
    Other Expenses
    		 n/a n/a 23.05K n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 10.86M 9.03M 14.98M 8.45M 7.72M 10.7M 10.44M 10.13M 9.84M 9.6M
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 -336.2K 336.2K -28.06K 18.38K 7.11K 18.64K 24.44K 15.23K -22.43K 33.33K
    Cost & Expenses
    		 10.92M 9.09M 15.1M 8.52M 7.77M 10.75M 10.46M 10.16M 9.88M 9.64M
    Income Tax Expense
    		 68.06K -1.61M -2.07M -1.9M -1.53M -2.28M -2.47M -2.13M -2.24M -1.88M
    Shares Outstanding (Basic)
    		 12.47M 8.54M 10.51M 4.17M 4.07M 4.02M 4.01M 4.01M 3.47M 2.21M
    Shares Outstanding (Diluted)
    		 12.47M 8.86M 10.51M 4.17M 4.07M 4.02M 4.01M 4.01M 3.47M 2.21M
    EPS (Basic)
    		 -0.42 -0.84 -1.2 -1.56 -1.44 -1.98 -1.56 -1.62 -1.92 -3.9
    EPS (Diluted)
    		 -0.42 -0.84 -1.2 -1.56 -1.44 -1.98 -1.56 -1.62 -1.92 -3.9
    EBITDA
    		 -7.11M -7.53M -14.62M -8.33M -7.25M -10.26M -8.71M -8.69M -8.95M -10.41M
    EBIT
    		 -7.12M -7.54M -14.69M -8.41M -7.3M -10.31M -8.73M -8.72M -8.99M -10.45M
    Depreciation & Amortization
    		 11.45K 16.86K 73.61K 73.92K 52.27K 50K 22.68K 31.54K 39.74K 35.63K

    Add to Watchlist